Zephirus

Zephirus combines budesonide and salmeterol for inhalation to support respiratory health. This combination therapy helps manage symptoms related to asthma and COPD. Suitable for adults and children as prescribed. A trusted option for long-term airway maintenance.

Zephirus is used to control and prevent symptoms of asthma and chronic obstructive pulmonary disease (COPD). It combines an inhaled corticosteroid (budesonide) to reduce inflammation and a long-acting beta agonist (salmeterol) to help open airways. This dual-action approach supports breathing comfort and reduces flare-ups when used regularly.

Users may experience improved breathing and reduced wheezing after consistent use. Some may notice a decrease in coughing and chest tightness. Effects vary by individual and may take time to become noticeable. Regular use is important for best results.

Keep Zephirus away from children and pets. Store in a dry place at room temperature. Avoid exposing the inhaler to extreme heat or moisture. Always check the expiration date before use. Consult a healthcare provider if symptoms worsen or do not improve.

Zephirus may interact with other inhaled medications or drugs affecting heart rhythm. Avoid using with strong CYP3A4 inhibitors unless directed. Alcohol and certain antibiotics may alter effects. Inform your healthcare provider about all medications and supplements in use.